Analyzing the Profitability's Impact on Firm Value During COVID-19

Amidst the COVID-19 epidemic, the specific impact of pharmaceutical companies' financial prowess on their overall worth remains uncertain. While many studies have explored the correlation between business value and various internal and external factors, the existing literature has not adequately focused on the precise influence of firm profitability on firm value, especially in the context of an epidemic. This article aims to fill a research gap by examining the relationship between profitability and corporate value during the COVID-19 pandemic, specifically focusing on Pfizer. This article utilizes a quantitative analysis technique. This research has developed a quantitative analytical approach to precisely measure the impact of profitability, which is an independent variable, on company value, which is a dependent variable. The investigation indicates a robust and favorable correlation between business value and sales growth. Due to the strong positive association between vaccine revenue and stock prices, it is advisable for corporate directors and strategic planners to emphasize vaccination production and sales.